Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
- 29 November 2006
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 131 (5), 1584-1591
- https://doi.org/10.1053/j.gastro.2006.08.043
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Proteomic identification of proteins conjugated to ISG15 in mouse and human cellsBiochemical and Biophysical Research Communications, 2005
- Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathwaysProceedings of the National Academy of Sciences, 2005
- Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral InfectionGastroenterology, 2005
- Protein ISGylation modulates the JAK-STAT signaling pathwayGenes & Development, 2003
- Lipopolysaccharide Activates the Expression of ISG15-specific Protease UBP43 via Interferon Regulatory Factor 3Published by Elsevier BV ,2002
- UBP43 (USP18) Specifically Removes ISG15 from Conjugated ProteinsJournal of Biological Chemistry, 2002
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and CirrhosisNew England Journal of Medicine, 2000
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arraysProceedings of the National Academy of Sciences, 1998
- Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cellsNature, 1979